Embecta Corp. (FRA:JX7)

Market Cap	649.54M
Revenue (ttm)	920.82M
Net Income (ttm)	81.31M
Shares Out	n/a
EPS (ttm)	1.38
PE Ratio	7.99
Forward PE	4.37
Dividend	0.53 (5.13%)
Ex-Dividend Date	Dec 5, 2025

Volume	n/a
Average Volume	21
Open	10.40
Previous Close	9.50
Day's Range	10.40 - 10.40
52-Week Range	7.80 - 19.90
Beta	n/a
RSI	56.10
Earnings Date	Feb 6, 2026

About Embecta

Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company’s products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient’s diabetes. It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, Inc. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1924
• Employees: 1,850
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: JX7

Financial Performance

In 2025, Embecta's revenue was $1.08 billion, a decrease of -3.80% compared to the previous year's $1.12 billion. Earnings were $95.40 million, an increase of 21.84%.

Financial numbers in USD